EuropaBio Newsletter 13

EuropaBio's Weekly Newsletter

Parliament adopts circular economy report

EuropaBio keenly welcomes the adoption by the European Parliament of the own-initiative report of Finnish MEP Sirpa Pietikäinen on "Resource efficiency: moving towards a circular economy", yet cautions against the application of the cascading principle transversally and indiscriminately across the bioeconomy. Read more about the resolution and EuropaBio's position

The state of healthcare biotech in Europe

Thanks to the application of modern biotechnology, progress made over the past decade in the understanding of the molecular processes behind diseases have enabled scientists to identify new targets for the development of medicines and make new cutting-edge therapies available to patients. In order to continue to foster such breakthroughs, European and national policy makers must tackle remaining challenges to the sustainability of the healthcare biotech sector. Read more in our animated online report

Relive EuropaBio's 3rd event on the Benefits of Biotechnology
through this best of video

FDA, EC & EMA hold hands

The United States Food and Drug Administration (FDA), the European Commission and the European Medicines Agency (EMA) have decided to reinforce their ongoing cooperative activities and strategic priorities for the next two years, including on rare diseases and biosimilars. Read more

Ministers slam GM import proposal

At a meeting on June 13, the majority of agriculture ministers expressed scepticism about the Commission’s proposal, particularly criticising the fact that the executive had not assessed the impact of the plan, and questioning how national bans could be compatible with the internal market rules as set out in the EU Treaty. Read more in EndsEurope

Innovation goes on and on

The first bio-based smartphone will soon go on sale. With a front panel made out of bioplastic instead of glass, it offers higher resistance to impact, heat, and weather than conventional engineering plastics. In addition, it has excellent transparency and low optical distortion. Read more in Il bioeconomista

Key dates to keep in mind

July 19-22: Bio World Congress on Industrial Biotechnology (Montreal, Canada)
September 9-10: Nordic Life Science Days (Stockholm, Sweden)
October 12-18: European Biotech Week
October 27-29: European Forum for Industrial Biotechnology and the Bioeconomy (Brussels, Belgium)